Matt Davidson reports a conversion at Azora Therapeutics

By AlphaYouPublished Nov 5, 2026Form 4

Stocks in this disclosure

Reported activity

Davidson Matt

Reporting filer

Matt Davidson reports a conversion, not an open-market purchase or sale, in Azora Therapeutics, Inc. (DE). Form 4 filed Nov 4, 2026 lists 4 entries.

Disclosed: Nov 4, 2026

Reported details

4 entries

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Davidson Matt	2026-11-02	C	Conversion	524954	Not stated (see footnotes)	819,018	2 days	Filed terms security Title: Common Stock transaction Date: 2026-11-02 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 524954 id: F1 transaction Acquired Disposed Code: A shares Owned Following Transaction: 819018 direct Or Indirect Ownership: D
Common Stock	Davidson Matt	2026-11-02	C	Conversion	101298	Not stated (see footnotes)	104,725	2 days	Filed terms security Title: Common Stock transaction Date: 2026-11-02 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 101298 id: F1 transaction Acquired Disposed Code: A shares Owned Following Transaction: 104725 direct Or Indirect Ownership: I nature Of Ownership: By Matt and Alli Davidson Trust id: F3
Series A Preferred Stock (derivative)	Davidson Matt	2026-11-02	C	Conversion	524.954	0	1,297.176	2 days	Filed terms security Title: Series A Preferred Stock id: F1 transaction Date: 2026-11-02 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 524.954 transaction Price Per Share: 0 transaction Acquired Disposed Code: D id: F2 id: F1 underlying Security Title: Common Stock underlying Security Shares: 524954 id: F1 shares Owned Following Transaction: 1297.176 direct Or Indirect Ownership: D
Series A Preferred Stock (derivative)	Davidson Matt	2026-11-02	C	Conversion	101.298	0	0	2 days	Filed terms security Title: Series A Preferred Stock id: F1 transaction Date: 2026-11-02 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 101.298 transaction Price Per Share: 0 transaction Acquired Disposed Code: D id: F2 id: F1 underlying Security Title: Common Stock underlying Security Shares: 101298 id: F1 shares Owned Following Transaction: 0 direct Or Indirect Ownership: I nature Of Ownership: By Matt and Alli Davidson Trust id: F3

Common Stock

Owner: Davidson Matt
Date: 2026-11-02
Code: C
Action: Conversion
Quantity: 524954
Price: Not stated (see footnotes)
Following holdings: 819,018
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-11-02
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 524954
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 819018
direct Or Indirect Ownership: D

Common Stock

Owner: Davidson Matt
Date: 2026-11-02
Code: C
Action: Conversion
Quantity: 101298
Price: Not stated (see footnotes)
Following holdings: 104,725
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-11-02
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 101298
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 104725
direct Or Indirect Ownership: I
nature Of Ownership: By Matt and Alli Davidson Trust
id: F3

Series A Preferred Stock (derivative)

Owner: Davidson Matt
Date: 2026-11-02
Code: C
Action: Conversion
Quantity: 524.954
Price: 0
Following holdings: 1,297.176
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Series A Preferred Stock
id: F1
transaction Date: 2026-11-02
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 524.954
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F2
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 524954
id: F1
shares Owned Following Transaction: 1297.176
direct Or Indirect Ownership: D

Series A Preferred Stock (derivative)

Owner: Davidson Matt
Date: 2026-11-02
Code: C
Action: Conversion
Quantity: 101.298
Price: 0
Following holdings: 0
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Series A Preferred Stock
id: F1
transaction Date: 2026-11-02
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 101.298
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F2
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 101298
id: F1
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: By Matt and Alli Davidson Trust
id: F3

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Davidson Matt: President and CEO, Director.
F1: Subject to certain beneficial ownership and other limits set forth in the Certificate of Designation of the Series A Preferred Stock, each share of Series A Preferred Stock converted into 1,000 shares of the Issuer's common stock and has no expiration date.
F2: The Series A Preferred Stock converted automatically within three days of Issuer's stockholders approving a proposal for the issuance of Issuer common stock upon conversion of the Series A Preferred Stock pursuant to the terms of the Agreement and Plan of Merger, dated June 11, 2026 ("Merger Agreement"), by and among the Issuer, Adial Merger Sub, Inc., a wholly owned subsidiary of the Issuer, Adial Second Merger Sub, LLC, a wholly owned subsidiary of the Issuer, and a private Delaware corporation that was then known as Azora Therapeutics, Inc.
F3: The Reporting Person serves as co-trustee of the Matt and Alli Davidson Trust.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Stock

Davidson Matt

2026-11-02

Conversion

524954

Not stated (see footnotes)

819,018

2 days

Filed terms

security Title: Common Stock
transaction Date: 2026-11-02
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 524954
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 819018
direct Or Indirect Ownership: D

Common Stock

Davidson Matt

2026-11-02

Conversion

101298

Not stated (see footnotes)

104,725

2 days

Filed terms

security Title: Common Stock
transaction Date: 2026-11-02
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 101298
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 104725
direct Or Indirect Ownership: I
nature Of Ownership: By Matt and Alli Davidson Trust
id: F3

Series A Preferred Stock (derivative)

Davidson Matt

2026-11-02

Conversion

524.954

1,297.176

2 days

Filed terms

security Title: Series A Preferred Stock
id: F1
transaction Date: 2026-11-02
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 524.954
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F2
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 524954
id: F1
shares Owned Following Transaction: 1297.176
direct Or Indirect Ownership: D

Series A Preferred Stock (derivative)

Davidson Matt

2026-11-02

Conversion

101.298

2 days

Filed terms

security Title: Series A Preferred Stock
id: F1
transaction Date: 2026-11-02
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 101.298
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F2
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 101298
id: F1
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: By Matt and Alli Davidson Trust
id: F3

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Davidson Matt: President and CEO, Director.

F1: Subject to certain beneficial ownership and other limits set forth in the Certificate of Designation of the Series A Preferred Stock, each share of Series A Preferred Stock converted into 1,000 shares of the Issuer's common stock and has no expiration date.

F2: The Series A Preferred Stock converted automatically within three days of Issuer's stockholders approving a proposal for the issuance of Issuer common stock upon conversion of the Series A Preferred Stock pursuant to the terms of the Agreement and Plan of Merger, dated June 11, 2026 ("Merger Agreement"), by and among the Issuer, Adial Merger Sub, Inc., a wholly owned subsidiary of the Issuer, Adial Second Merger Sub, LLC, a wholly owned subsidiary of the Issuer, and a private Delaware corporation that was then known as Azora Therapeutics, Inc.

F3: The Reporting Person serves as co-trustee of the Matt and Alli Davidson Trust.